A májzsírosodás és a hepatitis C-vírus-fertõzés

Translated title of the contribution: Fatty liver and hepatitis C virus infection

Lakatos Marianna, K. Hagymási, G. Lengyel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55%. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.

Original languageHungarian
Pages (from-to)1513-1519
Number of pages7
JournalOrvosi Hetilap
Volume152
Issue number38
DOIs
Publication statusPublished - Sep 1 2011

Fingerprint

Virus Diseases
Fatty Liver
Hepacivirus
Antiviral Agents
Insulin Resistance
Chronic Hepatitis C
Liver Diseases
Hepatocellular Carcinoma
Fibrosis
Obesity
Viruses
Therapeutics
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A májzsírosodás és a hepatitis C-vírus-fertõzés. / Marianna, Lakatos; Hagymási, K.; Lengyel, G.

In: Orvosi Hetilap, Vol. 152, No. 38, 01.09.2011, p. 1513-1519.

Research output: Contribution to journalArticle

Marianna, Lakatos ; Hagymási, K. ; Lengyel, G. / A májzsírosodás és a hepatitis C-vírus-fertõzés. In: Orvosi Hetilap. 2011 ; Vol. 152, No. 38. pp. 1513-1519.
@article{4532e19560174fc0bcf862cbf063533e,
title = "A m{\'a}jzs{\'i}rosod{\'a}s {\'e}s a hepatitis C-v{\'i}rus-fert{\~o}z{\'e}s",
abstract = "Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55{\%}. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.",
keywords = "antiviral treatment, Hepatitis C virus, insulin resistance, steatosis",
author = "Lakatos Marianna and K. Hagym{\'a}si and G. Lengyel",
year = "2011",
month = "9",
day = "1",
doi = "10.1556/OH.2011.29209",
language = "Hungarian",
volume = "152",
pages = "1513--1519",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "38",

}

TY - JOUR

T1 - A májzsírosodás és a hepatitis C-vírus-fertõzés

AU - Marianna, Lakatos

AU - Hagymási, K.

AU - Lengyel, G.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55%. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.

AB - Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55%. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.

KW - antiviral treatment

KW - Hepatitis C virus

KW - insulin resistance

KW - steatosis

UR - http://www.scopus.com/inward/record.url?scp=80052472686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052472686&partnerID=8YFLogxK

U2 - 10.1556/OH.2011.29209

DO - 10.1556/OH.2011.29209

M3 - Article

C2 - 21896442

AN - SCOPUS:80052472686

VL - 152

SP - 1513

EP - 1519

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 38

ER -